Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Ghadeer K Dawwas"'
Autor:
James D. Lewis, Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N. Naegeli, Ghadeer K. Dawwas
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 403-412 (2024)
Abstract Background Bowel urgency is a highly burdensome symptom among patients with inflammatory bowel disease (IBD). Objectives To assess changes in severity of bowel urgency and identify predictors of worsening or improvement among patients with C
Externí odkaz:
https://doaj.org/article/f17390a0c6ee45e5af7597538ea0fd14
Autor:
Cheng Chen, Sean Hennessy, Colleen M. Brensinger, Emily K. Acton, Warren B. Bilker, Sophie P. Chung, Ghadeer K. Dawwas, John R. Horn, Todd A. Miano, Thanh Phuong Pham Nguyen, Charles E. Leonard
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Drug interactions involving benzodiazepines and related drugs (BZDs) are increasingly recognized as a contributor to increased risk of unintentional traumatic injury. Yet, it remains unknown to what extent drug interaction triads (3DIs) may
Externí odkaz:
https://doaj.org/article/863d6552694c41f8a3429b96706fcd46
Autor:
Charles E. Leonard, Colleen M. Brensinger, Ghadeer K. Dawwas, Rajat Deo, Warren B. Bilker, Samantha E. Soprano, Neil Dhopeshwarkar, James H. Flory, Zachary T. Bloomgarden, Joshua J. Gagne, Christina L. Aquilante, Stephen E. Kimmel, Sean Hennessy
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background The low cost of thiazolidinediones makes them a potentially valuable therapeutic option for the > 300 million economically disadvantaged persons worldwide with type 2 diabetes mellitus. Differential selectivity of thiazolidinedion
Externí odkaz:
https://doaj.org/article/7be6dabc839f4bdbb7f63feb7e38ed6d
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 3, Pp n/a-n/a (2021)
ABSTRACT Aims To compare rates of use and adherence for newer versus older second‐line diabetes drug classes in commercially insured, Medicare Advantage and dual‐eligible (covered by both Medicare and Medicaid) patients. Materials and Methods Lon
Externí odkaz:
https://doaj.org/article/717ddd14716d421094cbd9f0ced71b3e
Autor:
Charles E. Leonard, Colleen M. Brensinger, Thanh Phuong Pham Nguyen, John R. Horn, Sophie Chung, Warren B. Bilker, Sascha Dublin, Samantha E. Soprano, Ghadeer K. Dawwas, David W. Oslin, Douglas J. Wiebe, Sean Hennessy
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 130, Iss , Pp 110531- (2020)
Background: Efforts to minimize harms from opioid drug interactions may be hampered by limited evidence on which drugs, when taken concomitantly with opioids, result in adverse clinical outcomes. Objective: To identify signals of opioid drug interact
Externí odkaz:
https://doaj.org/article/fd6a7a9c408e4979b787885473c933fd
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-9 (2018)
Abstract Background Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have found cardioprotective e
Externí odkaz:
https://doaj.org/article/43a5d546cb6d4f42adf25fd298be3824
Autor:
Michael D, Kappelman, Sruthi, Adimadhyam, Laura, Hou, Audrey E, Wolfe, Samantha, Smith, Andrew L, Simon, Érick, Moyneur, Juliane S, Reynolds, Sengwee, Toh, Angela, Dobes, Lauren E, Parlett, Kevin, Haynes, Mano, Selvan, Qianli, Ma, Vinit, Nair, Jessica, Burris, Jennifer E, Dorand, Ghadeer K, Dawwas, James D, Lewis, Millie D, Long
Publikováno v:
American Journal of Gastroenterology. 118:674-684
Many patients with Crohn's disease (CD) lose response or become intolerant to antitumor necrosis factor (TNF) therapy and subsequently switch out of class. We compared the effectiveness and safety of ustekinumab to vedolizumab in a large, geographica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce194440dd26ba70e0f92d7d97dc2928
https://doi.org/10.14309/ajg.0000000000002068
https://doi.org/10.14309/ajg.0000000000002068
Autor:
Ghadeer K Dawwas, Alexandra Weiss, Brad D Constant, Lauren E Parlett, Kevin Haynes, Jeff Yufeng Yang, Colleen Brensinger, Qufei Wu, Virginia Pate, Michele Jonsson Funk, Douglas E Schaubel, Andres Hurtado-Lorenzo, Michael David Kappelman, James D Lewis
Publikováno v:
Inflammatory Bowel Diseases.
Background To facilitate inflammatory bowel disease (IBD) research in the United States, we developed and validated claims-based definitions to identify incident and prevalent IBD diagnoses using administrative healthcare claims data among multiple p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0c190444322fd20ce8946ddcc38da15
https://doi.org/10.1093/ibd/izad053
https://doi.org/10.1093/ibd/izad053
Autor:
Ghadeer K. Dawwas, Geoffrey D. Barnes
Publikováno v:
Current Cardiology Reports. 24:731-738
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57603d2619dcdece001428a945ebd656
https://doi.org/10.1007/s11886-022-01690-9
https://doi.org/10.1007/s11886-022-01690-9
Publikováno v:
Diabetes Care
OBJECTIVE To assess the association of sodium–glucose cotransporter 2 (SGLT2) inhibitors with diabetic ketoacidosis compared with dipeptidyl peptidase 4 (DPP-4) inhibitors and sulfonylureas in patients with type 2 diabetes. RESEARCH DESIGN AND METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5702976da02579a59dd4e70f8cbc1c8f
https://doi.org/10.2337/dc21-2177
https://doi.org/10.2337/dc21-2177